Feb 20, 2020
Ablative Solutions Announces Publication of Data from the Peregrine Post-Market Study in the Journal of the American College of Cardiology: Cardiovascular Interventions
May 22, 2019
Renal Denervation Market Worth $1.03 Billion by 2026 | CAGR 43.2%: Grand View Research, Inc.
Mar 17, 2019
ReCor Medical Announces 6 Month On-Medication Results from RADIANCE-HTN SOLO Clinical Trial and the First Randomization in the RADIANCE-II Pivotal Study
Nov 20, 2018
Global Renal Denervation Market 2018-2026: Growing Incidences of Hypertension, Changing Lifestyle, and Enduring Effect of Renal Denervation Procedures
Nov 13, 2018
Growing Adoption of Electrophysiology Ablation Devices Dominating Unmet Technology Industry
Oct 16, 2018
Novel Radiometry Guided Microwave Ablation Technology Set to Advance with National Institutes of Health Small Business Innovation Research Award
Jul 10, 2018
Otsuka Medical Devices, Otsuka Holdings and ReCor Medical Announce Signing of Merger Agreement
Jul 02, 2018
ReCor Medical Announces FDA Approval Of IDE For Pivotal Study Of Paradise® Ultrasound Denervation System For Treatment Of Hypertension
May 23, 2018
ReCor Medical Announces RADIANCE-HTN SOLO Hypertension Study Meets Primary Efficacy Endpoint, Pivotal Study Submission, and New Principal Investigator
May 17, 2018
ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris
Mar 26, 2018
Pythagoras Medical Receives CE-Mark for the ConfidenHT(TM) System
Jan 05, 2018
ReCor Medical Announces Completion of RADIANCE-HTN SOLO Hypertension Study
Oct 30, 2017
ReCor Medical Announces 1000th Enrollment and 150th Randomization in RADIANCE-HTN Hypertension Study
Aug 30, 2017
Ablative Solutions Announces Presentation at the Baird Global Healthcare Conference